- Home
- SRPT vs NWBI Comparison
SRPT vs NWBI Comparison
Compare SRPT & NWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRPT | NWBI |
|---|---|---|
| Founded | 1980 | 1896 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2000 | 2009 |
Fundamental Metrics
Financial Performance| Metric | SRPT | NWBI |
|---|---|---|
| Price | $18.95 | $15.84 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 24 | 8 |
| Target Price | ★ $21.64 | $16.43 |
| AVG Volume (30 Days) | ★ 2.6M | 1.1M |
| Earning Date | 11-05-2026 | 10-26-2026 |
| Dividend Yield | N/A | ★ 5.16% |
| EPS Growth | N/A | ★ 16.46 |
| EPS | ★ 2.99 | 0.71 |
| Revenue | ★ $2,198,237,000.00 | N/A |
| Revenue This Year | N/A | $11.47 |
| Revenue Next Year | N/A | $4.86 |
| P/E Ratio | ★ $6.20 | $21.83 |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $14.68 | $11.25 |
| 52 Week High | $24.68 | $16.16 |
Technical Indicators
Market Signals| Indicator | SRPT | NWBI |
|---|---|---|
| Relative Strength Index (RSI) | 50.57 | 57.13 |
| Support Level | $18.38 | $15.17 |
| Resistance Level | $19.71 | $15.73 |
| Average True Range (ATR) | 0.95 | 0.29 |
| MACD | 0.13 | 0.06 |
| Stochastic Oscillator | 62.56 | 69.70 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution, offering personal and commercial banking solutions, business services, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and Commercial Banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Commercial Banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.